company background image
RICH logo

Laboratorios RichmondC.I.F BASE:RICH Stock Report

Last Price

AR$998.50

Market Cap

AR$80.6b

7D

-0.2%

1Y

94.6%

Updated

16 Jun, 2024

Data

Company Financials

Laboratorios Richmond S.A.C.I.F.

BASE:RICH Stock Report

Market Cap: AR$80.6b

RICH Stock Overview

A pharmaceutical company, develops and manufactures pharmaceutical products.

RICH fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health1/6
Dividends0/6

Laboratorios Richmond S.A.C.I.F. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Laboratorios RichmondC.I.F
Historical stock prices
Current Share PriceAR$998.50
52 Week HighAR$1,235.00
52 Week LowAR$480.50
Beta0.37
1 Month Change11.56%
3 Month Change18.59%
1 Year Change94.64%
3 Year Change316.04%
5 Year Change2,169.32%
Change since IPO2,598.65%

Recent News & Updates

Recent updates

Shareholder Returns

RICHAR PharmaceuticalsAR Market
7D-0.2%-0.4%4.0%
1Y94.6%-28.4%277.6%

Return vs Industry: RICH exceeded the AR Pharmaceuticals industry which returned -28.4% over the past year.

Return vs Market: RICH underperformed the AR Market which returned 277.3% over the past year.

Price Volatility

Is RICH's price volatile compared to industry and market?
RICH volatility
RICH Average Weekly Movement5.0%
Pharmaceuticals Industry Average Movement5.0%
Market Average Movement7.3%
10% most volatile stocks in AR Market9.7%
10% least volatile stocks in AR Market5.5%

Stable Share Price: RICH has not had significant price volatility in the past 3 months.

Volatility Over Time: RICH's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1935620Juan Manuel Artolawww.richmondlab.com

Laboratorios Richmond S.A.C.I.F., a pharmaceutical company, develops and manufactures pharmaceutical products. It provides antiretroviral products for the treatment of human immunodeficiency virus (HIV); oncology and oncohematology drugs; cardiometabolic drugs, including antihypertensive, hypocholesterolemic, platelet antiaggregants, and hypoglycemic drugs; and neurological and psychiatric drugs comprising analgesic, antipsychotic, antidepressants, anti-dementia, antiepileptics, and hypnotic drugs, as well as drugs for the treatment of multiple sclerosis. The company sells its products in Latin America, Africa, Asia, and the Middle East.

Laboratorios Richmond S.A.C.I.F. Fundamentals Summary

How do Laboratorios RichmondC.I.F's earnings and revenue compare to its market cap?
RICH fundamental statistics
Market capAR$80.63b
Earnings (TTM)-AR$4.26b
Revenue (TTM)AR$35.89b

2.2x

P/S Ratio

-18.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RICH income statement (TTM)
RevenueAR$35.89b
Cost of RevenueAR$16.55b
Gross ProfitAR$19.34b
Other ExpensesAR$23.60b
Earnings-AR$4.26b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-52.80
Gross Margin53.88%
Net Profit Margin-11.88%
Debt/Equity Ratio255.2%

How did RICH perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.